_2020091018165303jzv.jpg "Decoding The World Of ETF")
My Account
The new coronavirus strain, first discovered in the central city of Wuhan, has caused alarm because of its connection to Severe Acute Respiratory Syndrome (SARS), which killed nearly 650 people across mainland China and Hong Kong in 2002-2003. More
Feb 20, 2021 10:53 PM IST The mutated version of coronavirus could 'escape' through the immune system developed by the body. In such a scenario, maintaining COVID-19-approporiate behaviour is of utmost necessity to reduce the pace of transmission, said Dr Randeep Guleria.
Feb 18, 2021 09:47 AM IST India, which has reported the highest number of overall COVID-19 cases after the United States, detected the South African variant in four people last month and the Brazilian one in one person this month.
Feb 08, 2021 05:37 PM IST Three months ended December 31 saw a 1.6 times ad volume growth compared to the first three months of 2020, data from the TAM AdEx report showed.
Feb 08, 2021 09:47 AM IST As per a statement from the company, all employees with one year of service or greater will receive a bonus, the equivalent of 10 days’ salary
Jan 22, 2021 12:43 PM IST The overall incidence of 'adverse events' was 14–21 percent in all vaccine-treated groups, says the data published in Lancet. The company says the incidence of adverse events are noticeably lower than the rates for other SARS-CoV-2 vaccine platform candidates.
Jan 21, 2021 03:25 PM IST CEO Adar Poonawalla said equipment worth hundreds of crores were damaged in the fire, and the company is expected to face revenue loss of more than Rs 1,000 crore over the next one to two years.
Jan 15, 2021 10:31 AM IST “There is a clear correlation between the news of the vaccine rollout and hiring picking up," Sanjay Shetty, Head - strategic account management at Randstad India, said.
Jan 05, 2021 02:03 PM IST The poll was conducted by the Confederation of Indian Industry (CII), India’s oldest and largest industry body, exclusively for Moneycontrol. It took responses from more than 80 CEOs of the country’s top business houses. In it, the corporate honchos laid down their expectations from the government in and beyond the Union Budget 2021-22, as well as their thoughts on the economy in 2021.
Jan 05, 2021 01:23 PM IST The approval of Covaxin, which is still undergoing phase-3 clinical trials and yet to have efficacy data, has been roundly criticised. But Krishna Ella, Chairman and Managing Director of Bharat Biotech, the maker of Covaxin, feels a lot of that criticism is not justified. Here’s a look at what he had to say about its efficacy and immunogenicity data, administering it in ‘clinical trial mode’ and whether it is just a ‘back-up’ vaccine
Jan 05, 2021 12:36 PM IST Bharat Biotech Chairman Krishna Ella apparently hit back at Serum Institute of India chief Adar Poonawalla’s jibe calling vaccines other than those by AstraZeneca, Moderna and Pfizer as 'like water'.
Jan 04, 2021 06:46 PM IST The Drug Controller General of India (DCGI) on January 3 granted permission for restricted emergency use of the AstraZeneca-Oxford University and Bharat Biotech Covid-19 vaccines. The approval was based on the recommendations of the Subject Expert Committee (SEC), which reviewed the data on safety and immunogenicity of the two vaccines. However, post the announcement it is India’s indigenous vaccine which has found itself in the middle of a controversy. Here’s why.
Dec 30, 2020 06:48 PM IST In view of the COVID-19 pandemic, the Central Board of Indirect Taxes and Customs has also extended the due date for filing annual return under the Central Goods and Services Tax Act, 2017, to February 28.
Dec 30, 2020 03:19 PM IST The subject expert committee of the India's Central Drugs Standard Control Organisation is likely to meet later on December 30 to examine SII's emergency-use authorisation application for Oxford-AstraZeneca’s vaccine.
Dec 25, 2020 02:39 PM IST A dry run has been planned in four states to prepare for COVID-19 vaccine administration and assess readiness.
Dec 24, 2020 10:15 PM IST Cadila Healthcare said its vaccine was found to be well tolerated and immunogenic in the Phase I/II clinical trials.
Dec 17, 2020 08:46 PM IST As India prepares for a mass rollout of the COVID-19 vaccines, reports suggest that the country may need close to $1.8 billion to fund the first phase of the vaccination drive. This edition of Business Insight has everything you need to know about the drive.
Dec 15, 2020 07:53 AM IST Bourla told CNN in an interview that Pfizer is still negotiating with the U.S. on whether it will be able to deliver the vaccine in the second or third quarter of the year.
Dec 14, 2020 05:10 PM IST The Health Ministry has issued operational guidelines for the COVID-19 vaccination drive. The standard operating procedure (SOP) has been shared with all states and Union territories. Watch the video to know more
Dec 10, 2020 04:22 PM IST Bharat Biotech’s COVID-19 vaccines were "not considered" for emergency use authorisation on December 9 over lack of data. But what is emergency use authorisation and how is it different from full approval? What is the process of getting a EUA in India and is it safe to use? What are the risks involved? Here are four key questions answered about the new COVID-19 buzz word - EUA
Dec 09, 2020 10:02 AM IST After evaluation, the panel will recommend to the DCGI whether emergency use approval for the vaccine candidates should be granted or not.
Dec 08, 2020 10:24 AM IST Until early this year, the company had around 10,000 employees in the country. Now, the number is estimated to have come down to less than 2,500, with Oyo shifting to a lean model and exiting operations and renovations.
Dec 07, 2020 06:50 PM IST Serum Institute is now seeking the DCGI nod For emergency use authorisation of its vaccine candidate Covishield In India. More here.
Dec 07, 2020 02:31 PM IST According to the research published in the journal Cell, the new diagnostic test can not only generate a positive or negative result, it also measures the viral load -- the concentration of virus -- in a given sample.
Dec 07, 2020 07:57 AM IST The U.S. company, whose vaccine was recently approved in Britain, approached Indian authorities on Saturday, V.K. Paul, who is advising the government on COVID-19 matters, said.
Dec 07, 2020 07:56 AM IST SII is the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking authorisation for a coronavirus vaccine in India.
